- Home
- FEMY vs ALGS Comparison
FEMY vs ALGS Comparison
Compare FEMY & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- ALGS
- Stock Information
- Founded
- FEMY 2004
- ALGS 2018
- Country
- FEMY United States
- ALGS United States
- Employees
- FEMY N/A
- ALGS N/A
- Industry
- FEMY Medical/Dental Instruments
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- FEMY Health Care
- ALGS Health Care
- Exchange
- FEMY Nasdaq
- ALGS Nasdaq
- Market Cap
- FEMY N/A
- ALGS 27.9M
- IPO Year
- FEMY 2021
- ALGS 2020
- Fundamental
- Price
- FEMY $1.14
- ALGS $5.25
- Analyst Decision
- FEMY Strong Buy
- ALGS Strong Buy
- Analyst Count
- FEMY 2
- ALGS 1
- Target Price
- FEMY $11.50
- ALGS $70.00
- AVG Volume (30 Days)
- FEMY 233.4K
- ALGS 184.7K
- Earning Date
- FEMY 05-08-2025
- ALGS 05-06-2025
- Dividend Yield
- FEMY N/A
- ALGS N/A
- EPS Growth
- FEMY N/A
- ALGS N/A
- EPS
- FEMY N/A
- ALGS N/A
- Revenue
- FEMY $1,629,108.00
- ALGS $3,945,000.00
- Revenue This Year
- FEMY $441.89
- ALGS $580.86
- Revenue Next Year
- FEMY $101.29
- ALGS N/A
- P/E Ratio
- FEMY N/A
- ALGS N/A
- Revenue Growth
- FEMY 51.97
- ALGS N/A
- 52 Week Low
- FEMY $0.86
- ALGS $3.76
- 52 Week High
- FEMY $1.80
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- FEMY 41.61
- ALGS 34.94
- Support Level
- FEMY $1.07
- ALGS $4.33
- Resistance Level
- FEMY $1.29
- ALGS $6.00
- Average True Range (ATR)
- FEMY 0.09
- ALGS 0.72
- MACD
- FEMY 0.01
- ALGS 0.50
- Stochastic Oscillator
- FEMY 39.13
- ALGS 65.18
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.